205 related articles for article (PubMed ID: 19816666)
1. Refractory chronic immune thrombocytopenic purpura in a child with acute lymphoblastic leukemia.
Horino S; Rikiishi T; Niizuma H; Abe H; Watanabe Y; Onuma M; Hoshi Y; Sasahara Y; Yoshinari M; Kazama T; Hayashi Y; Kumaki S; Tsuchiya S
Int J Hematol; 2009 Nov; 90(4):483-485. PubMed ID: 19816666
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of rituximab therapy and splenectomy in childhood chronic and refractory immune thrombocytopenic purpura.
Ay Y; Karapinar TH; Oymak Y; Toret E; Demirag B; Ince D; Ozcan E; Moueminoglou N; Koker SA; Vergin C
Blood Coagul Fibrinolysis; 2016 Jun; 27(4):431-5. PubMed ID: 26656905
[TBL] [Abstract][Full Text] [Related]
3. Idiopathic thrombocytopenic purpura following successful treatment of acute lymphoblastic leukemia.
Tannir NM; Kantarjian H
Leuk Lymphoma; 2001 Mar; 41(1-2):217-20. PubMed ID: 11342378
[TBL] [Abstract][Full Text] [Related]
4. Treatment of immune thrombocytopenic purpura associated with cytomegalovirus infection in a child with pre-B cell acute lymphoblastic leukaemia after central nervous system relapse.
Martinez AR; Paul MR; Kuo DJ
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28947425
[TBL] [Abstract][Full Text] [Related]
5. Refractory immune thrombocytopenic purpura (ITP) after accessory splenectomy: A case report and literature review.
Riaz A; Ali HT; Ali F; Ali J
Clin Hemorheol Microcirc; 2023; 85(2):189-194. PubMed ID: 37599530
[TBL] [Abstract][Full Text] [Related]
6. Immune thrombocytopenic purpura secondary to SARS-CoV-2 infection in a child with acute lymphoblastic leukaemia: a case report and review of literature.
Dongre A; Jameel PZ; Deshmukh M; Bhandarkar S
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34740909
[TBL] [Abstract][Full Text] [Related]
7. Immune Thrombocytopenic Purpura During Maintenance Phase of Acute Lymphoblastic Leukemia: A Rare Coexistence Requiring a High Degree of Suspicion, a Case Report and Review of the Literature.
Bayhan T; Ünal Ş; Gümrük F; Çetin M
Turk J Haematol; 2015 Dec; 32(4):363-6. PubMed ID: 25913619
[TBL] [Abstract][Full Text] [Related]
8. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
10. Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura.
Mahey R; Kaur SD; Chumber S; Kriplani A; Bhatla N
BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24363245
[TBL] [Abstract][Full Text] [Related]
11. 5- to 16-year follow-up following splenectomy in chronic immune thrombocytopenic purpura in children.
El-Alfy MS; El-Tawil MM; Shahein N
Acta Haematol; 2003; 110(1):20-4. PubMed ID: 12975552
[TBL] [Abstract][Full Text] [Related]
12. Immune thrombocytopenia in association with acute lymphoblastic leukaemia and a haemophagocytic syndrome.
Campbell JK; Mitchell CA
Eur J Haematol; 1993 Oct; 51(4):259-61. PubMed ID: 7694874
[No Abstract] [Full Text] [Related]
13. Management of adult idiopathic thrombocytopenic purpura.
Nakhoul IN; Kozuch P; Varma M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute immune thrombocytopenic purpura.
Tarantino MD; Goldsmith G
Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura.
Pasa S; Altintas A; Cil T; Danis R; Ayyildiz O
J Thromb Thrombolysis; 2009 Apr; 27(3):329-33. PubMed ID: 18311541
[TBL] [Abstract][Full Text] [Related]
16. Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
Blackhouse G; Xie F; Levine MA; Campbell K; Assasi N; Gaebel K; O'Reilly D; Tarride J; Goeree R
J Popul Ther Clin Pharmacol; 2012; 19(2):e166-78. PubMed ID: 22580389
[TBL] [Abstract][Full Text] [Related]
17. Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura.
Holt D; Brown J; Terrill K; Goldsby R; Meyers RL; Heximer J; Nordfors B; Slayton WB
Pediatrics; 2003 Jan; 111(1):87-90. PubMed ID: 12509559
[TBL] [Abstract][Full Text] [Related]
18. Is splenectomy necessary for immune thrombocytopenic purpura? The role of rituximab in patients with corticosteroid resistance in a single-center experience.
Zhang C; Liu HF; Chen XH; Gao L; Gao L; Liu Y; Kong PY; Sun AH; Zhang X
Clin Ther; 2014 Mar; 36(3):385-8. PubMed ID: 24594069
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy.
Griffiths J; Sia W; Shapiro AM; Tataryn I; Turner AR
J Obstet Gynaecol Can; 2005 Aug; 27(8):771-4. PubMed ID: 16287009
[TBL] [Abstract][Full Text] [Related]
20. Management of chronic immune thrombocytopenic purpura in children and adults.
Blanchette V; Freedman J; Garvey B
Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
